U.S. Physical Therapy (USPH)
(Real Time Quote from BATS)
$97.40 USD
+2.92 (3.09%)
Updated Jul 16, 2024 12:44 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
USPH 97.40 +2.92(3.09%)
Will USPH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for USPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USPH
AMED or USPH: Which Is the Better Value Stock Right Now?
AMED vs. USPH: Which Stock Is the Better Value Option?
USPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
AMED vs. USPH: Which Stock Should Value Investors Buy Now?
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise
U.S. Physical Therapy (USPH) Misses Q1 Earnings Estimates
Other News for USPH
U.S. Physical Therapy to Present at the CJS Securities 24th Annual New Ideas Summer Conference
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
U.S. Physical Therapy to Present at the 14th Annual East Coast IDEAS Conference 2024
US Physical Therapy CEO to Present at IDEAS Conference
U.S. Physical Therapy Breaks Below 200-Day Moving Average - Notable for USPH